The Food and Drug Law Institute, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. The scope of FDLI includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco. FDLI is a not-for-profit 501(c)(3) organization. FDLI does not engage in advocacy activities.

    FDLI’s Mission is to provide education, training, and publications on topical food and drug law; act as a liaison to promote networking as a means to develop professional relationships and idea generation; and ensure an open, balanced marketplace of ideas to inform innovative public policy, law, and regulation.

    Read More

    The Story and the Rest of the Story with Pitts and Goldberg
    November 2015 (Policy Forum)

    Bringing Your Pharmaceutical Drug to Market with Ralph Hall, Matt Hill, Neil Di Spirito
    April 2015 (Book)

    What Does the Future Hold for Patient-Focused Drug Development? with Nick Manetto, FaegreBD Consulting and David Zook, Faegre Baker Daniels
    October 2015 (Policy Forum)

    Food and Drug Law and Regulation, 3rd Edition with David G. Adams, Richard M. Cooper, Martin J. Hahn & Jonathan S. Kahan, Editors
    March 2015 (Book)

    Advancing More Predictive Preclinical Testing Tools with Elizabeth Baker, Tamara Drake, Robert Coleman, Kathy Archibald, and Katya Tsaioun
    September 2015 (Policy Forum)